Davenport & Co’s Encompass Health EHC Stock Holding History

Davenport & Co’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,292	Closed	-$275K	–	1078
2021 Q4	$275K	Buy	+5,292	New	+$273K	﹤0.01%	944

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Davenport & Co's EHC Position: Q1 2022 in Review

Davenport & Co sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 5,292 shares — an estimated $275K sold.

Davenport & Co first reported a position in EHC in Q4 2021 and held it in 1 quarter. The position peaked at $275K in Q4 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

Davenport & Co reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
Davenport & Co sold 5,292 Encompass Health shares in Q1 2022, an estimated $275K.
Davenport & Co first reported a position in Encompass Health in Q4 2021 and held it in 1 quarter.
Davenport & Co's Encompass Health position peaked at $275K in Q4 2021.
406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Davenport & Co's 13F filing for Q1 2022, filed 2 May 2022.